MiMedx Group (NASDAQ:MDXG) Releases Earnings Results, Hits Estimates

MiMedx Group (NASDAQ:MDXG) released its earnings results on Wednesday. The company reported $0.07 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.07, Zacks reports. MiMedx Group had a net margin of 23.86% and a return on equity of 26.21%.

MiMedx Group Price Performance

MDXG stock traded up $0.05 during mid-day trading on Wednesday, hitting $8.01. The company had a trading volume of 562,154 shares, compared to its average volume of 563,991. The company has a 50-day moving average price of $8.78 and a 200 day moving average price of $7.68. MiMedx Group has a 12-month low of $5.47 and a 12-month high of $10.14. The company has a market capitalization of $1.18 billion, a price-to-earnings ratio of 14.56 and a beta of 1.94. The company has a quick ratio of 3.53, a current ratio of 4.10 and a debt-to-equity ratio of 0.10.

Analysts Set New Price Targets

Separately, StockNews.com downgraded MiMedx Group from a “strong-buy” rating to a “buy” rating in a research report on Friday, November 8th. Six analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of $12.00.

About MiMedx Group

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins.